PA
KBR icon

PharVision Advisers’s KBR KBR Stock Holding History

PharVision Advisers’s Portfolio KBR Stock Details KBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,996
Closed -$241K – 385
2025
Q4 		$241K Buy
+5,996
New +$257K 0.12% 421
2025
Q2 		– Sell
-7,581
Closed -$378K – 357
2025
Q1 		$378K Buy
7,581
+2,266
+43% +$121K 0.52% 48
2024
Q4 		$308K Buy
+5,315
New +$339K 0.26% 143

Other funds holding KBR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's KBR Position: Q1 2026 in Review

PharVision Advisers sold out of KBR (KBR) in Q1 2026, closing a stake of 5,996 shares — an estimated $241K sold.

PharVision Advisers first reported a position in KBR in Q4 2024 and held it in 3 quarters. The position peaked at $378K in Q1 2025. 370 funds tracked by Wall St. Rank hold KBR as of Q1 2026.

  • PharVision Advisers reported no remaining KBR position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 5,996 KBR shares in Q1 2026, an estimated $241K.
  • PharVision Advisers first reported a position in KBR in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's KBR position peaked at $378K in Q1 2025.
  • 370 funds tracked by Wall St. Rank held KBR as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.